Sepracor-Looks very promising | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Sepracor-Looks very promising

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
10280	115	0	SEPR

Emcee: rkrw	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
9830	Clearly the stock was weak today, but still OK over the two dy period. Maybe it	Rocky9	-	11/8/2006
9829	SEPR is pharma not biotech for purposes of how it moves with Congressional moods	Robohogs	-	11/7/2006
9828	We can test this theory if you wish. Why don't you provide really great numb	Iamarangerboy	-	11/7/2006
9827	I agree that that trivial news is not likely what elevated the stock today. Perh	Iamarangerboy	-	11/7/2006
9826	It seems hard to believe that this news is the reason for today's move. Vol	Rocky9	-	11/7/2006
9825	XOPENEX HFA(R) Data to Be Presented at American College of Allergy, Asthma and I	Iamarangerboy	-	11/7/2006
9824	thanks, Rocky	Iamarangerboy	-	11/6/2006
9823	Lunesta 137,851 tot Xop MDI 27,340 tot	Rocky9	-	11/6/2006
9822	So in short nbix has to do the entire phase III all over again.	rkrw	-	11/3/2006
9821	I see it's time for your annual check-in. Hope all is well! Cheers, Tuck	tuck	-	11/3/2006
9820	From Merrill Disaster scenario for Indiplon; slow cash bleed likely Neurocrine’	Vector1	-	11/3/2006
9819	nbix took huge hit in after market with good volume.... someone did not like wha	Iamarangerboy	-	11/3/2006
9818	This is like third or fourth day in a row where either the pre-mkt bid or after-	Robohogs	-	11/2/2006
9817	Re Indiplon - biz.yahoo.com It looks like it is still a long time away. The NB	Rocky9	-	11/2/2006
9816	No argument from me. You'd think they'd at least get a weak formulation	rkrw	-	11/2/2006
9815	Ya, I know about the generic challenge. But what makes the CR any more vulnerab	kenhott	-	11/2/2006
9814	Generics have already filed paragraph iv challenges to CR. From what I understan	rkrw	-	11/2/2006
9813	Thx. Was it just CFSB or others too? CR was approved as a new dosage formulat	kenhott	-	11/2/2006
9812	ETrade has it - not Ameritrade (at least not my account). Jon	Robohogs	-	11/1/2006
9811	Duplicate post	Rocky9	-	11/1/2006
9810	The CSFB report (available at Ameritrade, I think - I got it through another ful	Rocky9	-	11/1/2006
9809	<i>AmbienCR goes generic in '08</i> Does mean that that the det	Biomaven	-	11/1/2006
9808	Who are saying that CR is going generic in 08?? Thx.	kenhott	-	11/1/2006
9807	It does bring up the fact that it will take a very strong competitor for most in	Robohogs	-	10/31/2006
9806	A couple interesting assumptions in one of the reports were: 1) AmbienCR goes g	Rocky9	-	10/31/2006

Go to reply# or date (mm/dd/yy):